These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20471605)

  • 1. Catechol derivatives inhibit the fibril formation of amyloid-beta peptides.
    Huong VT; Shimanouchi T; Shimauchi N; Yagi H; Umakoshi H; Goto Y; Kuboi R
    J Biosci Bioeng; 2010 Jun; 109(6):629-34. PubMed ID: 20471605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct observation of amyloid growth monitored by total internal reflection fluorescence microscopy.
    Ban T; Goto Y
    Methods Enzymol; 2006; 413():91-102. PubMed ID: 17046392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
    Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
    Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid disrupts in vitro amyloid beta(1-40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats.
    Hashimoto M; Shahdat HM; Yamashita S; Katakura M; Tanabe Y; Fujiwara H; Gamoh S; Miyazawa T; Arai H; Shimada T; Shido O
    J Neurochem; 2008 Dec; 107(6):1634-46. PubMed ID: 19014387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
    Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
    Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of dendrimer's structure on its activity against amyloid fibril formation.
    Klajnert B; Cortijo-Arellano M; Cladera J; Bryszewska M
    Biochem Biophys Res Commun; 2006 Jun; 345(1):21-8. PubMed ID: 16674918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
    Dolphin GT; Chierici S; Ouberai M; Dumy P; Garcia J
    Chembiochem; 2008 Apr; 9(6):952-63. PubMed ID: 18330854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interactions of dendrimers with amyloid peptides: pH dependence.
    Klajnert B; Cladera J; Bryszewska M
    Biomacromolecules; 2006 Jul; 7(7):2186-91. PubMed ID: 16827586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenolic oxime oligomers inhibit Alzheimer's amyloid fibril formation and disaggregate fibrils in vitro.
    Dolphin GT; Renaudet O; Ouberai M; Dumy P; Garcia J; Reymond JL
    Chembiochem; 2009 May; 10(8):1325-9. PubMed ID: 19415707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct observation of Abeta amyloid fibril growth and inhibition.
    Ban T; Hoshino M; Takahashi S; Hamada D; Hasegawa K; Naiki H; Goto Y
    J Mol Biol; 2004 Nov; 344(3):757-67. PubMed ID: 15533443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovine colostrum nanopeptide affects amyloid beta aggregation.
    Janusz M; Woszczyna M; Lisowski M; Kubis A; Macała J; Gotszalk T; Lisowski J
    FEBS Lett; 2009 Jan; 583(1):190-6. PubMed ID: 19084010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization and classification of amyloid beta supramolecular assemblies.
    Yagi H; Ban T; Morigaki K; Naiki H; Goto Y
    Biochemistry; 2007 Dec; 46(51):15009-17. PubMed ID: 18044976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and biological activity of beta-sheet breaker peptide conjugates.
    Rocha S; Cardoso I; Börner H; Pereira MC; Saraiva MJ; Coelho M
    Biochem Biophys Res Commun; 2009 Mar; 380(2):397-401. PubMed ID: 19250644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.
    Soto C; Kindy MS; Baumann M; Frangione B
    Biochem Biophys Res Commun; 1996 Sep; 226(3):672-80. PubMed ID: 8831674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.
    Ono K; Hasegawa K; Naiki H; Yamada M
    J Neurosci Res; 2004 Mar; 75(6):742-50. PubMed ID: 14994335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro.
    Ono K; Hirohata M; Yamada M
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1046-52. PubMed ID: 16460684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation.
    Crouch PJ; Tew DJ; Du T; Nguyen DN; Caragounis A; Filiz G; Blake RE; Trounce IA; Soon CP; Laughton K; Perez KA; Li QX; Cherny RA; Masters CL; Barnham KJ; White AR
    J Neurochem; 2009 Mar; 108(5):1198-207. PubMed ID: 19141082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the amyloid-beta(1-40) fibril environment with substituted tryptophan residues.
    Touchette JC; Williams LL; Ajit D; Gallazzi F; Nichols MR
    Arch Biochem Biophys; 2010 Feb; 494(2):192-7. PubMed ID: 19995549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.